Skip to content

Guido Serini

  • MD PhD
  • Group Leader
  • Candiolo Cancer Institute
  • 32h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 4025CitationsNumber of citations received by Guido's publications. Updated daily.

Research interests

PlexinsNeuropilinsSemaphorinsCancerAngiogenesisEndothelial cellsTrafficExtracellular matrixIntegrins

About

Our lab tries to grasp the molecular mechanisms by which cells adhere to and move through the body environment in cancer, vascular and rare genetic diseases.

Co-authors (219)

Publications (5)

  • A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent

    • Gioelli N
    • Maione F
    • Camillo C
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program

    • Regano D
    • Visintin A
    • Clapero F
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • TRPM8 inhibits endothelial cell migration via a nonchannel function by trapping the small GTPase Rap1

    • Genova T
    • Grolez G
    • Camillo C
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism

    • Torchiaro E
    • Lorenzato A
    • Olivero M
    • et al.
    N/AReaders
    1Citations
  • Phase separation in eukaryotic directional sensing

    • Gamba A
    • De Candia A
    • Di Talia S
    • et al.
    N/AReaders
    0Citations
    Get full text

Professional experience

Group Leader

Candiolo Cancer Institute

January 2009 - Present